Product Categories
| Country: | China |
|---|---|
| Tel: | |
| Mobile: | +8613726739909 |
| E-mail: | pengguizi@cti-cert.com |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| N1,N2-Dinitroso Tadalafil Impurity 1 | Details |
| Orforglipron Impurity 5 | C7H4BrFN2 | 1082041-85-7 | Details |
| Orforglipron Impurity 14 | C12H18N2O3 | 2212021-56-0 | Details |
| Orforglipron Impurity 13 | Details |
| Orforglipron Impurity 12 | C18H20FN5O | 2212021-62-8 | Details |
| Orforglipron Impurity 11 | C20H27ClN4O2 | 2212021-92-4 | Details |
| Orforglipron Impurity 10 HCl | C8H11ClN2.ClH | 2212021-93-5 | Details |
| Orforglipron Impurity 9 | C14H24N2O4 | 2212021-58-2 | Details |
| Orforglipron Impurity 8 HCl | Details |
| Orforglipron Impurity 7 | Details |
| Suzetrigine Impurity 5 | C7H8N2O2 | 71469-93-7 | Details |
| Suzetrigine Impurity 3 | C14H15F5O3 | 3041980-36-0 | Details |
| Suzetrigine Impurity 2 | C5H7F3O2 | 2875067-31-3 | Details |
| Orforglipron Impurity 19 | C28H36FN5O5 | 2923760-40-9 | Details |
| Seladelpar Impurity 5 | C10H9F3O2 | 256372-58-4 | Details |
| Seladelpar Impurity 4 | C11H14O3S | 343322-82-7 | Details |
| Orforglipron Impurity 6 | C21H20N2 | 210536-89-3 | Details |
| Suzetrigine Impurity 6 | C14H13F5O3 | 2875066-38-7 | Details |
| Suzetrigine Impurity 4 | 2875067-17-5 | Details |
| Suzetrigine Impurity 1 | C9H9FO3 | 886498-61-9 | Details |
| Seladelpar Impurity 6 | C21H23F3O5S | 851528-81-9 | Details |
| Seladelpar Impurity 3 | C23H27F3O5S | 851528-83-1 | Details |
| Seladelpar Impurity 1 | C11H14O3 | 93917-68-1 | Details |
| Suzetrigine Impurity 7 | C15H15F5O4 | 2649470-87-9 | Details |
| Naltrexone methylbromide Impurity01 | Details |
| Naltrexone methylbromide Impurity04 | Details |
| Naltrexone methylbromide Impurity03 | Details |
| Naltrexone methylbromide Impurity02 | Details |
| Baricitinib Impurity 02 | C16H18N6O4S | Details |
| Trazodone hydrochloride Impurity | Details |
| Baricitinib Impurity 07 | C18H21N7O2S | Details |
| Baricitinib Impurity 06 | C17H20N6O4S | Details |
| 4,4',4''-TRI-TERT-BUTYL-2,2':6',2''-TERPYRIDINE | C27H35N3 | 115091-29-7 | Details |
| Oseltamivir-Sorbitol Adduct | C22H38N2O9 | Details |
| Dabrafenib Impurity M | C24H23F2N5O3S2 | Details |
| Dabrafenib Impurity N | C17H18FN5S | Details |
| Dabrafenib Impurity T | C13H9F3N2O3S | Details |
| Dabrafenib Impurity E | C23H21F2N5O2S2 | Details |
| Dabrafenib Impurity A | C23H19F3N4O3S2 | Details |
| Dabrafenib Impurity G | C18H13F3N4O3S | Details |
| Dabrafenib Impurity B | C23H20F3N5O2S2 | 1195765-44-6 | Details |
| Sugammadex Impurity 9 | C72H113NaO48S9 | 2412952-92-0 | Details |
| Dabrafenib Impurity C | C23H20F3N5O2S2 | Details |
| Dabrafenib Impurity 7 | C27H31N2NaO6S2 | Details |
| Dabrafenib Impurity O | C23H22F2N6O2S2 | 2017554-98-0 | Details |
| Dabrafenib Impurity J | C22H18F3N5O2S2 | 1195765-47-9 | Details |
| Sugammadex Impurity 6 | C69H109NaO47S7 | 2376607-99-5 | Details |
| Sugammadex Impurity 10 | 2412953-06-9 | Details |
| Tigecycline Epimer | C29H39N5O8 | 1422262-97-2 | Details |
| Oseltamivir Citrate Impurity 2 | C22H34N2O10 | 2738248-87-6 | Details |
| Oseltamivir Citrate Impurity 1 | C22H34N2O10 | 2738248-86-5 | Details |
| Sancycline Epi-Isomer | C21H22N2O7 | 906364-49-6 | Details |
| Oseltamivir Impurity 1 | C22H32N2O6 | 2413185-87-0 | Details |
| Oseltamivir-Fructose Adduct 2 | C22H38N2O9 | Details |
| Oseltamivir Citrate Impurity 3 | C38H60N4O13 | Details |
| Oseltamivir Citrate Impurity 5 | C38H60N4O13 | Details |
| Oseltamivir Citrate Impurity 4 | C39H61N3O13 | Details |
| Oseltamivir-Fructose Adduct 1 | C22H38N2O9 | Details |
| Oseltamivir-Glucose Adduct 1 | Details |
| Canagliflozin Peroxide Impurity | C24H25FO7S | 2247196-28-5 | Details |
| Entecavir Lactose Adduct Impurity 2 | C24H35N5O13 | Details |
| Entecavir Lactose Adduct Impurity 1 | C24H35N5O13 | Details |
| 20-alpha-Dihydro Dydrogesterone | C21H30O2 | 4243-74-7 | Details |
| Bumetanide Glucose Impurity | C23H30N2O10S | Details |
| Sitafloxacin Impurity 3 | C23H10Cl2F4N2O6 | Details |
| Sitafloxacin Impurity 1 | C19H19ClF2N4O2 | Details |
| Sitafloxacin Impurity 2 | C23H10Cl2F4N2O6 | Details |
| N-nitroso Viloxazine | C13H18N2O4 | 3033383-17-1 | Details |
| N-Methyl Viloxazine | C14H21NO3 | 48173-47-3 | Details |
| N-Nitroso Benazepril | Details |
| Atrasentan Impurity 20 | Details |
| Atrasentan Impurity 18 | Details |
| Sorafenib Impurity 03 | C6H4ClNO2 | 5470-22-4 | Details |
| Sorafenib Impurity 02 | C6H5NO2 | 98-98-6 | Details |
| Sorafenib Impurity 10 | Details |
| Sorafenib N-Oxide | C21H16ClF3N4O4 | 583840-03-3 | Details |
| Sorafenib Impurity 09 | C13H12N2O2 | 2004659-85-0 | Details |
| Sorafenib Impurity 08 | C20H19N5O3 | 2004659-83-8 | Details |
| Sorafenib EP Impurity A | C13H13N3O2 | 284462-37-9 | Details |
| Sorafenib Impurity 06 | C7H7ClN2O | 220000-87-3 | Details |
| Sorafenib EP Impurity I | C15H8Cl2F6N2O | 370-50-3 | Details |
| Sorafenib Impurity 13 | C8H6ClF3N2O | 343247-69-8 | Details |
| Sorafenib Impurity 12 | C14H10ClF3N2O2 | 1129683-83-5 | Details |
| Sorafenib Impurity 01 | C7H6ClNO2 | 24484-93-3 | Details |
| Trametinib Impurity 08 | Details |
| Trametinib Impurity 06 | Details |
| Trametinib Impurity 01 | Details |
| Azilsartan Impurity 160 | Details |
| Pivmecillinam dimer | Details |
| Biapenem dimer impurity 2 | Details |
| Enzalutamide Impurity 12 | C12H11F3N2OS | 2088914-60-5 | Details |
| Enzalutamide Impurity 13 | C11H9F3N2OS | 2088914-59-2 | Details |
| Atosiban Impurity 53 | Details |
| Atosiban Impurity 55 | Details |
| Viloxazine Impurity 5 | C19H24O5 | 3024393-81-2 | Details |
| Viloxazine Impurity 4 | C26H38N2O6 | 744994-03-4 | Details |
| Viloxazine Impurity 6 | C13H12D5NO4 | Details |
| Atosiban Impurity 56 | Details |
| Atosiban Impurity 52 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 | ||||